Click for next page ( 90

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement

Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter. Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.

Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.

OCR for page 89
6 Biographical Sketches K ENT BLAIR is a Vic - President of Donaldson, Lufkin dc Jenrette Securities Corporation. He holds a B.A. from Colgate University and an M.S. in industrial administration from Carnegie- Alellon University. Mr. Kent was employed by Merck dc Co., Inc. from 1963 to 1968, where he held a number of positions in sales, marketing, production, and finance. In 1968 he joined the i nstitutional investment research firm of Auerbach, Pollack dc Richardson as a Vice-President and Director, serving as the health industries analyst. C HARLES C. EDWARDS is President of Scripps Clinic and Research Foundation. Dr. Edwards holds a B.A. and M.D. from the Un iversity of Colorado and an M.A. from the University of Minnesota. During his career, he has been in private practice as a surgeon, served on the staff of The George Washington University, and was a Vice-President and Managing Officer at Booz, Allen, dc Hamilton. Or. Edwards was also the Commissioner of the Food and Drug Administration from 1969 to 1973 and Assistant Secretary for Health, Education, and Welfare from 1973 to 1975. Dr. Edwards serves on a number of professional committees and b cards including service as president of the National Health Council, trustee~t-large of the National Kidney Foundation, and a member of the Policy Advisory Committee of the National Board of Medical Examiners. W ILLIAM N. HUBBARD, JR. is President of the Upjohn Company, Inc. He received an A.B. from Columbia University, did postgraduate work at the University of North Carolina School of Medicine, and received an M.D. from New York University. Dr. Hubbard has taught at several universities and was the dean of the University of Michigan Medical School. He joined Upjohn in 1970 and has served as its President since 1974. Dr. Hubbard's professional memberships include the National Science Board of 89

OCR for page 89
9o the National Science Foundation, the New York Academy of Medicine, and the Board of Regents of the National Library of M edicine. PETER B. HUTT is a Partner in Covington and Burling. He received a B.A. from Yale, an L.L.B from Harvard, and an L.L.M. from New York University. From 1971 to 1975 he served as Chief Counsel for the FDA and Assistant General Counsel for HEW. Mr. Hutt is a member of a number of professional and honorary societies including the National Academy of Sciences' Institute of Medicine. He has received a number of awards including the HEW Distinguished Service award and the Underwood-Prescott award from MIT. He is the comuthor of Dealing with Drug Abuse. PHILIP R. LEE is Professor of Social Medicine and th e Hi rector of the Health Policy Program at the University of California Medical School, San Francisco. He received an A.B. from Stanford and an M.D. and M.S. from the University of - ~ . . ~ ~ ~ ~ ~ 1 Minnesota. Alter working several years al Tne resew fork University Schoolof Medicine and the Palo Alto Medical Clinic, Dr. Lee served as Deputy Assistant Secretary and as Assistant Secretary of Health and Science Affairs at the U.S. Department of Health, Education, and Welfare from 1 965 to 1969. He has received a number of awards including the AID Superior Honor award, is a member of several professional societies, and has contributed to a number of medical and scientific journals. ARTHUR M. SACKLER is a research professor of Psychiatry at New York Medical College and the Publisher of the Medical Tribune Newspapers. He holds a B.S. and an M.D. from New York University. Dr. Sackler has been the founder or co-founder of a number of institutions including the Creedmoor Institute to r Psvchobiolo~ical Studies and the Sackler School of Medicine in _ . . . . . . , . . . . ~ ~l~el-Avlv. He has spent much OI nls career In psycnlaTry ana In promoting medical communication as Chairman of the Board of the Medical Press. Inc. and President of the Physicians News , Service, Inc. and the Medical Radio and TV Institute, Inc. Dr. Sackler has received a number of awards and is a member of numerous professional organizations including a Fellow of the American Psychiatric Association and an Associate of the Linus Pauling Institute of Science and Medicine. LEWIS H. SARETT has recently retired as Senior Vice- President of Merck & Co., Inc. He holds a B.S. and D.Sc. from Northwestern and a Ph.D. from Princeton. Dr. Sarett has spent most of his professional career with Merck dc Co., having worked as Assistant Director of Organic and Biological Research, as

OCR for page 89
91 Vi cc-President for Basic Research, and as President of Merck Sharp dc Dohme Research Laboratories. A member of a number of professional and honorary organizations including the National Academy of Sciences, Dr. Sarett has received numerous awards including the Perkin Medal, the Merck Directors award, the William Scheele Lecture award of the Royal Pharmaceutical Institute in Sweden, the Northwestern Alumni Association Award of Merit, and an American Chemical Society award for creative w ark in synthetic organic chemistry. - He has served on the Chemical and Engineering News editorial board and has contributed numerous articles to professional publications. LACY GLENN THOMAS is Professor of Business at the Columbia University Graduate School of Business. He holds a B.A. from Vanderbilt University and an M.A. and Ph.D. from Duke University. Dr. Thomas held a position at the University of Illinois as Professor of Economics and was a research fellow at The Brookings Institution. He is the author or co author of several papers and articles including "Estimating the Effects of Regulation on Innovation: An International Comparative Analysis of the Pharmaceutical Industry" published in the Journal of Law and Economics. WILLIAM M. WARDELL is Professor of Pharmacology and Director of the Center for the Study of Drug Development at the University of Rochester Medical Center. He has attended Canterbury University and Otago University Medical School in New Zealand, holds a B.S. in physiology; a D.Phil. (Ph.D.) and a B.M., B.Ch. (M.D.) from the University of Oxford (U.K.~; and a D.M. from the University of Rochester/Oxford. Dr. Wardell is a member of a number of professional and honorary societies including the Chairman of the Committee on Drug Development, National Council on Drugs, and the Corr mittee on Certification in Clinical Pharmacology, American Society for Clinical Pharma- cology and Therapeutics. He is the author or coauthor of nearly 100 papers and articles and has received several awards and honors including the University of Oxford Radcliffe Prize for Research in Medical Science and the Merck International Fellowship in Clinical Pharmacology. PAUL F. WEHRLE is Hastings Professor of Pediatrics at the University of Southern California and Director of Pediatrics, Pediatric Pavilion, Los Angeles County-University of Southern California Medical Center. He holds a B.S. from the University of Arizona and an A4.D. from Tulane University. Dr. Wherle has held university appointments at the University of Pittsburgh, The Johns Hopkins University, and the State University of New York

OCR for page 89
92 at Syracuse. He is author or coauthor of over 190 contributions concerning infectious disease or environmental hazards and is a m ember of a number of professional societies including the Infectious Disease Society of America, the Society for Pediatric R esearch, the American Association for the Advancement of Science, and the American Academy of Pediatrics. Dr. Wehrle has served as a member of numerous committees and organizations including the World Health Organization and the Expert Com- mittee on Viral Infections. A LBERT P. WILLIAMS is Director of the Health Sciences Program at The Rand Corporation. His formal education includes a B.S. in engineering from the U.S. Naval Academy and an M.A. in international relations, an M.A . in economics, and a Ph.D. i n economics from the Fletcher School of Tufts University. Before joining The Rand Corporation, Dr. Williams served on the White House staff and at the Bureau ~ the Budget. He received the Executive Office of the President Bureau of the Budget Profes- sional Achievement Award and is a member of several profess signal organizations including the American Association for the Advancement of Science and the American Economic Association. RICHARD D. WOOD is Chairman of the Board and Chief Executive Officer of Eli Lilly & Co. He holds a number of degrees including a B.S. from Purdue, an L.L.D. and M.B.A. from the University of Pennsylvania, an L.L.D from De Pauw University, an L.L.D. from the Philadelphia College of Pharmacy and Science, and a D.Sc. from Butler University. Dr. Wood has managed and directed Eli Lilly operations in Argentina, Mexico, and Central America. In 1970 he became President of Eli Lilly International Corporation and Chairman of the Board in 1973. Dr. Wood is a m ember of several business and professional organizations including the Business Roundtable, the Conference Board, and the Pharmaceutical Manufacturers' Association. ALEJANDRO ZAFFARONI is President and Director of Research of ALZA Corporation. He holds a B.S. from the University of Montevideo and a Ph.D. in biochemistry from the University of Rochester. Before founding ALZA in 1968, Dr. Zaffaroni progressed from Associate Director of Biological Research to President of Syntex Laboraties and Syntex Research. In 1972 Dr. Zaffaroni founded Dynapol, a company with a primary aim of developing safe food additives. He has received numerous awards including election as a member of the National Academy of Sciences' Institute of Medicine, Fellow of the American Academy of Arts and Sciences, and Fellow of the American Pharmaceutical Association.